1. Wenchao Li, SaiSai Chen, Jian Lu, Weipu Mao, Shiya Zheng, Minhao Zhang, Tiange Wu, Yurui Chen, Kai Lu, Chunyan Chu, Chuanjun Shu, Yue Hou, Xue Yang, Naipeng Shi, Zhijun Chen, Lihua Zhang, Lei Zhang, Rong Na, Ming Chen, Shenghong Ju, Dingxiao Zhang, Yi Ma*, Bin Xu*. YY1 enhances HIF-1α stability in tumor-associated macrophages to suppress anti-tumor immunity of prostate cancer in mice. Nature Communications, 2025,16(1):6261.
2. Li Feng, Xinjia Wang, Xinrui Guo, Liyuan Shi, Shihuang Su, Xinjing Li, Jia Wang, Ninghua Tan*, Yi Ma*, Zhe Wang*. Identification of Novel Target DCTPP1 for Colorectal Cancer Therapy with the Natural Small-Molecule Inhibitors Regulating Metabolic Reprogramming. Angewandte Chemie International Edition, 2024, 63(47): e202402543.
3. Li Zhou, Bin Yu, Mengqiu Gao, Rui Chen, Zhiyu Li, Yueqing Gu*, Jinlei Bian*, Yi Ma*. DNA framework-engineered chimeras platform enables selectively targeted protein degradation. Nature Communications, 2023, 14(1): 4510.
4. Wen Li#, Jiali Huang#, Chen Shen#, Weiye Jiang, Xi Yang, Jingxuan Huang, Yueqing Gu, Zhiyu Li*, Yi Ma*, Jinlei Bian*. Tumor-targeted metabolic inhibitor prodrug labelled with cyanine dyes enhances immunoprevention of lung cancer. Acta Pharmaceutica Sinica B, 2024, 14(2):751-764.
5. Ping Li, Qi Chang, Mengmeng Liu, Ke Lei, Shuai Ping, Jia Wang, Yueqing Gu*, He Ren*, Yi Ma*. DNA-Encoded and Spatial Proximity Replaced Glycoprotein Analysis Reveals Glycosylation Heterogeneity of Extracellular Vesicles. Analytical Chemistry, 2023, 95(48): 17467-17476.